UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 13, 2023
Accession Number:
0001193125-23-065380
Submission Type:
POS AM
CIK:
0001566373
Company Name:
F-star Therapeutics, Inc.
File Number:
333-215122